Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Imedb36on May 10, 2017 9:08am
218 Views
Post# 26224837

RE:RE:F U G L Y

RE:RE:F U G L Y

Mmm read all of information !

Reported Adjusted EBITDA1 of $84.2 million, compared to  $80.5 million in the fourth quarter of 2016. 4m$ better than last quarter -- > the compagny has stabilized

the Company launched one new product in an IMS  of $30 million. IMS value anticipated to be in excess of $100 million

In addition, the Company has eight products under active development that it anticipates will launch in the next three to five years.  IMS-measured market value expected to be in excess of $1 billion

Finally, Concordia has identified up to 21 additional products for future development with its network of external partners. If launched, these products are anticipated to compete in estimated current IMS measured markets that are expected to be worth hundreds of millions more.

 

<< Previous
Bullboard Posts
Next >>